Skip to main content

For informational and research purposes only.

Medical DisclaimerTerms of Use

Semax: The Definitive Guide

Russian nasal-drop doses, the spray and injection schedules people use, what the human studies found, and what users report.

Semax at a glance.

Semax infographic. Semax is a synthetic chain of seven amino acids, Met-Glu-His-Phe-Pro-Gly-Pro (MEHFPGP). Positions 1 to 4 come from the hormone ACTH, where they are positions 4 to 7, and positions 5 to 7 are an added Pro-Gly-Pro tail. Formula C37H51N9O10S, 813.9 grams per mole. How researchers think it works, in rat and cell studies and not proven in people: in rats, one nasal dose raised the brain growth protein BDNF up to 1.4-fold; in rat strokes, damaged areas were smaller and hundreds of genes shifted; in rodents, it raised a serotonin breakdown product and boosted amphetamine's effects. Discussed for focus and brain fog, stroke recovery, memory problems from poor brain circulation, and optic nerve disease. Typical labeled dose: 0.1% drops, 2 to 3 drops per nostril (200 to 300 micrograms), 2 to 4 times a day, for 3 to 14 days, depending on the use; online, the most common pattern is 200 to 600 micrograms a day as a nasal spray for about 2 weeks. Human evidence: small Russian studies, all given through the nose, mostly not randomized, and none tested everyday focus in healthy adults. Status: prescription medicine in Russia; not FDA-approved; not named on the WADA 2027 list.

Semax

A lab-made peptide built from a fragment of ACTH (the hormone that releases cortisol) with a Pro-Gly-Pro tail

Also called ACTH(4-7)-Pro-Gly-Pro, MEHFPGP or an “ACTH(4-10) analog” · Семакс in Russian

Not the same as N-acetyl Semax amidate (NASA), Adamax, Selank or semaglutide

7 amino acids C37H51N9O10S 813.9 g/mol Synthetic

  1. M, Met, position 1, nonpolar, contains sulfur
  2. E, Glu, position 2, acidic, negatively charged
  3. H, His, position 3, basic, can carry a positive charge
  4. F, Phe, position 4, aromatic, ring side chain
  5. P, Pro, position 5, proline
  6. G, Gly, position 6, nonpolar, smallest
  7. P, Pro, position 7, proline

Positions 1 to 4 come from the hormone ACTH, where they are positions 4 to 7; positions 5 to 7 are an added Pro-Gly-Pro tail.

Bead positions show order, not 3D structure.

  • Acidic(negatively charged): Glu
  • Basic(can carry a positive charge): His
  • Aromatic(ring side chain): Phe
  • Proline:Pro
  • Nonpolar:Met (contains sulfur), Gly

How researchers think it works

In rat and cell studies, not proven in people

  1. BDNF rise

    In rats, one nasal dose raised the brain growth protein BDNF up to 1.4‑fold.

    Animal study

  2. Stroke models

    In rat strokes, damaged areas were smaller and hundreds of genes shifted.

    Animal study

  3. Brain chemicals

    In rodents, it raised a serotonin breakdown product and boosted amphetamine's effects.

    Animal study

Discussed for

Focus and brain fog; stroke recovery; memory problems from poor brain circulation; optic nerve disease

Typical labeled dose

2–3 drops per nostril0.1% drops (200–300 mcg each time), 2–4 times a day, for 3–14 days, depending on the use

Russian label. Online, the most common pattern is 200–600 mcg a day as a nasal spray for about 2 weeks.

Human evidence

Small Russian studiesall given through the nose

Mostly not randomized; none tested everyday focus in healthy adults

Status

  • Prescription medicine in Russia
  • Not FDA-approved
  • Not named on the WADA 2027 list
Conceptual summary: bead positions show amino-acid order, not a 3D structure. Brain-signal findings come from rat and cell studies; the human studies gave Semax through the nose, mostly to Russian patients with stroke, brain-circulation and eye disease.
Published by DoserlyUpdated Next scheduled review: December 202635 min readHow this guide was made
In this guide

What is Semax?

Semax is a lab-made peptide, a short chain of seven amino acids, sold in Russia as a prescription nasal-drop medicine for stroke, memory and thinking problems caused by poor blood flow in the brain, and some eye-nerve diseases. Online it is popular as a "focus" or nootropic peptide. [1], [2], [3]

It was developed in the early 1980s at the Institute of Molecular Genetics in Moscow from a short piece of ACTH, the pituitary hormone that tells the adrenal glands to release cortisol. The developers took the four-amino-acid piece linked to learning in animal studies and added three more (Pro-Gly-Pro) to make it last longer. The result, Met-Glu-His-Phe-Pro-Gly-Pro (MEHFPGP), is often called an "ACTH(4-10) analog". In animal tests it did not act like the hormone, although one human study found cortisol higher (see how it might work). [4], [5], [6], [7], [8]

Semax is a registered medicine in Russia (0.1% nasal drops since 1994, according to the manufacturer, and a stronger 1% form for stroke) and investigational elsewhere: it is not approved by the US Food and Drug Administration (FDA), we found no approval in other countries we checked, and its human research is almost entirely Russian. [6], [1], [7]

Conceptual side view of the head showing the nasal cavity, the thin roof of the nose near the olfactory area, and the brain just above it. It shows the route nose drops take; it does not show a measured amount of Semax reaching the brain.
Semax is given as nose drops. Drops land on the nasal lining, where some is absorbed into the blood and, in rat studies, a small share reaches the brain within minutes. This generated illustration explains anatomy; it is not microscopy or clinical evidence.

Typical Semax Protocols

Intranasal drops (into each nostril) · licensed Semax 0.1% (50 mcg per drop) or 1% (500 mcg per drop) · Amounts in micrograms (mcg) · Current Russian label [1], [2], [9], [10]
Labeled useAmount each timeFrequencyTotal per dayCourse
Mental fatigue and adapting to heavy strain (0.1%)2–3 drops per nostril (200–300 mcg)2–3 times, in the first half of the day400–900 mcg3–5 days, repeated if needed
Memory and thinking problems from poor brain circulation (0.1%)2–3 drops per nostril (200–300 mcg); up to 2,000 mcg as repeated drops4 times a day800–8,000 mcg10–14 days, repeated if needed
Optic nerve disease (0.1%)2–3 drops per nostril2–3 times a day600–900 mcg (label figure; the drop count gives 400–900)7–10 days
Moderate acute ischemic stroke, with other stroke treatment (1%)2–3 drops per nostril (2,000–3,000 mcg)3–4 times a day, every 3–4 hours6,000–12,000 mcg10 days
Severe acute ischemic stroke, with other stroke treatment (1%)3–4 drops per nostril (3,000–4,000 mcg)4–5 times a day, every 2.5–3 hours12,000–20,000 mcg10 days

On the label, each 0.1% dose is 2–3 drops in each nostril (200–300 mcg); how often and for how long depend on the use, from 2–3 times a day for 3–5 days to 4 times a day for 10–14 days. The 1% stroke doses are much larger and given alongside standard stroke care. The label also covers recovery after head injury or brain surgery and a children's schedule from age 7 under medical care, not repeated here. [1], [2]

What doses do research nasal sprays use?

Outside Russia, most people use a spray mixed from a research-grade powder, not the licensed drops. These schedules come from protocol websites.

Home-made or ready-made intranasal spray · Semax alone · Amounts in micrograms (mcg) · Each row is one source's complete schedule: low [11], mid [12], high [13]
ExampleAmount each timeFrequencyTotal per dayDuration
Low200–600 mcgOnce daily, in the morning200–600 mcg5–14 days, then 14 days off
Mid200–300 mcg2–3 times, in the first half of the day400–900 mcg5 days (based on the label's fatigue course)
High200–600 mcg2–3 times a day400–1,800 mcg10–21 days, then 2–4 weeks off

The most common pattern in the reviewed sources is 200–600 mcg a day as a nasal spray, taken once in the morning or split into two or three sprays earlier in the day, for about 2 weeks. [14], [3], [15], [16]

What doses are used for Semax injections?

Subcutaneous injection (into the fatty layer under the skin) · Semax alone · Amounts in micrograms (mcg) · No human study has tested this route · Each row is one source's complete schedule: low [11], mid [17], high [18]
ExampleAmount each timeFrequencyTotal per dayDuration
Low250–500 mcgOnce daily250–500 mcg5–14 days, then 14 days off
Mid300–500 mcg a day in total, after 3–5 days at 200–300 mcg a dayIn the morning, with an optional second dose in late morning (split not stated)300–500 mcg10–14 days on, 2–3 days off; a 1–2-week break after 2–4 rounds
High600–1,000 mcg, after about a week at 300–500 mcgOnce daily, in the morning600–1,000 mcg2–4 weeks, then 1–2 weeks off

For injections, the recurring pattern is 200–500 mcg once a day, usually in the morning, for about 2 weeks, with some pages going to 1,000 mcg. [14], [13], [11], [17], [19]

Read these cautions before the numbers. Human studies gave Semax only through the nose, mostly at label-range doses in Russian patients, plus a few brief studies in healthy volunteers; the spray and injection schedules come from protocol websites, not trials. [1], [7]

  • Do not stop or cut back prescribed medicine to try Semax. That includes ADHD stimulants, antidepressants and mood stabilisers. Semax has never been tested as a replacement for any of them, and in rodents it strengthened amphetamine's effects. In community education groups, some people describe making these changes without their prescriber. [7]
  • The label rules it out with anxiety disorders, a history of seizures, acute psychiatric illness, and in pregnancy and breastfeeding. [1]
  • Children and teenagers. The 1% drops are for adults only, and the 0.1% label's one children's use (from age 7) is a prescription treatment. Home-made sprays and injections have never been studied in anyone under 18. [1], [2]
  • Home-made sprays and research-powder injections are unverified. Their strength, sterility and stability are unknown, no Semax spray pump has been tested, and there are no human safety data for injected Semax. [7]
  • Read the units. mcg means micrograms; 1 mg equals 1,000 mcg. A drop of licensed 0.1% Semax holds 50 mcg and a drop of 1% holds 500 mcg; a home-made spray holds whatever its mix and pump deliver. "Per nostril" amounts are half of the dose. On an insulin syringe, a unit measures liquid, not Semax; check any amount with the reconstitution calculator.
Titration Changing the amount in steps
The label gives a range for each use rather than steps, and larger label doses are reached by repeating drops 10–15 minutes apart. [1] Websites usually start at about 200 mcg and move up: one injection page rises to 500 mcg in two-week steps over six weeks, another from 200–300 mcg to 300–500 mcg after 3–5 days. [20], [17]
Breaks and cycles
For adults, the label gives fixed courses of 3–14 days (10 for stroke), and the children's course is 30 days; courses are repeated "if necessary" with no stated gap. Websites add breaks of 2–3 days to 4 weeks, or 5 days on and 2 off. No study has compared break lengths. [1], [17], [13], [21]

Low, mid and high are alternatives, not steps to move through. The cited references give the full details.

Where protocols differ: drops, sprays, injections and breaks ↓

Where these numbers come from

Label table. The rows reproduce the current Russian instructions for Semax 0.1% (registration of March 2025) and 1% (June 2025), checked against the Vidal drug reference and published transcriptions of the 2025 instructions, with the 2011 manufacturer instructions as a cross-check. Microgram amounts follow the label's own figures of 50 mcg per 0.1% drop and 500 mcg per 1% drop. Daily totals are the label's stated ranges: 2–3 drops per nostril four times a day works out to 800–1,200 mcg (the label allows up to 8,000 mcg through repeated drops), and the optic nerve schedule works out to 400–900 mcg although the label states 600–900 mcg. An older 2008 version of the instructions, still reproduced online, gives 500–5,000 mcg a day for 3–5 days and a lower minimum age; it is superseded. [1], [2], [9], [10], [22], [23], [24]

Spray and injection tables. Each row is one publisher's complete schedule: nasal low [11], mid [12] and high [13]; injection low [11], mid [17] and high [18]. We compared 32 dosing pages, mapped 12 provisional lineages of copied claims, and re-checked the principal dose figures against the live pages on September 23, 2026. The "most common pattern" sentences summarize the largest group of pages that state the same range (200–600 mcg a day by nose; 200–500 mcg a day by injection); no median is calculated because most pages give ranges, not single amounts. [14], [3], [15], [16]

We keep amounts, frequency and course length together, rather than taking a low number from one page and a duration from another. Pages with clear unit errors, weight-based "research" doses and stroke doses mislabelled as injections do not define the typical comparison. No page cites a human study for injected Semax; the FDA found none. [7], [25], [26]

Row-specific notes: the nasal mid row converts the label's 3–5-day fatigue course into spray volumes; the injection high row comes from a page that also gives intramuscular doses of 1–5 mg for stroke, which no study used. [12], [18]

Open the searchable source directory

What is Semax commonly used for?

Most people outside Russia look into Semax for focus, mental energy and "brain fog", often alongside ADHD (attention deficit hyperactivity disorder), long work days or recovery from illness. In Russia it is prescribed mainly after stroke and for memory problems caused by poor blood flow to the brain. [27], [28], [1]

The two rest on different evidence. The Russian studies tested nose drops in patients, while the focus use rests on personal accounts and animal research. The sections below keep them apart.

Bar chart of selected studies with reported group sizes, one per condition. Acute ischemic stroke: 120 given Semax and 40 given placebo, described as randomized, method not reported. Long-term poor brain circulation: 187 and 118 on usual care, not randomized. Optic nerve disease: 54 and 20 on usual care, not randomized. Psoriasis with metabolic syndrome: 60 and 58 on standard care, not randomized. Glaucoma: 24 and 12 on salt-water drops, allocation not described. Motor neuron disease: 27, no comparison group. Healthy volunteers, brain scans: 14 given one dose and 10 placebo. Everyday focus or memory in healthy adults: no trial found. All studies gave Semax through the nose; most come from the research network that developed Semax.

Where the human evidence on Semax is

Acute ischemic stroke
120 given Semax · 40 placeboDescribed as randomized, method not reported6, 12 or 18 mg/day for 5 days, 40 per dose
Long-term poor brain circulation
187 given Semax · 118 usual careComparison group, not randomizedrepeated 3-week courses
Optic nerve disease
54 given Semax · 20 usual careComparison group, not randomizeddrops or electrophoresis; controls also improved
Psoriasis with metabolic syndrome
60 given Semax · 58 standard careComparison group, not randomized600 mcg/day for 10 days; measured hormones
Glaucoma
24 given Semax · 12 salt-water dropsComparison group, allocation not described15-day course; both groups improved
Motor neuron disease
27 given Semax · No comparison groupNo comparison groupno effect on the disease
Healthy volunteers (brain scans)
14 given Semax · 10 placeboPlacebo comparison; single dose; scans onlybrain-network scans 5 and 20 minutes after one dose
Everyday focus or memory in healthy adults
No trial foundNo trial found

All studies gave Semax through the nose. Most come from the research network that developed Semax.

Most human studies are in patients, all given Semax through the nose; none tested everyday focus or memory in healthy adults.

Where the human evidence is. Each bar shows people given Semax and the comparison group in a selected study with reported group sizes for that condition, and whether the comparison was randomized. A 2012 glaucoma study of 110 people is not shown because it did not report clear group sizes. Most studies come from the developers' own research network, and none tested healthy adults' everyday focus or memory as an outcome. Sources: FDA briefing document, 2026 · Stroke methodological guide, 2011 · Brain-circulation study, 2005 · Optic nerve study, 2000 · Psoriasis study, 2014 · Glaucoma study, 2014 · Motor neuron disease study, 2007 · Healthy-volunteer brain scan study, 2018.

Focus, mental energy and brain fog

This is the main reason people try it, and the least studied. No trial has measured everyday focus, memory or productivity in healthy adults. The older healthy-volunteer studies measured alertness, brain waves or brain scans after one or a few doses. [7], [29]

The Russian label does list "prevention of mental fatigue", monotonous operator work and adapting to heavy strain as uses, with a 3–5-day course. We found no published trial of that course. [1]

ADHD and attention

The 0.1% label includes children aged 7 and over with minimal brain dysfunction, including ADHD. The only comparison we found is a Russian review's summary of a 2000 study in 78 children aged 7–10: after 30 days, 50% improved on Semax, 48% on piracetam (another nootropic drug) and 10% on a multivitamin. The original report could not be retrieved, and the summary does not say how children were assigned or whether anyone was blinded. The FDA did not evaluate ADHD because it found no supporting literature. Adult ADHD is a common reason people try Semax online; it has not been tested for it. [1], [30], [7]

Stroke recovery

This is where most of the human research is. Russian studies gave Semax through the nose at 6–24 mg a day in the first days after an ischemic stroke (one caused by a blocked artery), and report faster recovery of movement and other lost functions than usual care alone. The studies are mostly small, not randomized and run by the developers' network. The human research section gives the details. [31], [32], [33]

Conceptual view of a brain with a blocked artery, a core area of damaged tissue, and a surrounding zone of at-risk tissue that researchers hope to protect. It does not show a measured effect of Semax.
In an ischemic stroke, a blocked artery starves part of the brain. Tissue around the core can survive if it recovers quickly, and that at-risk zone is what the Russian stroke studies and rat stroke models aim to protect. This generated illustration explains anatomy; it is not microscopy or clinical evidence.

Memory problems from poor brain circulation, and eye disease

The label's main 0.1% use is memory and thinking problems from long-term poor blood flow to the brain and after mini-strokes, where two larger Russian studies report better function than in untreated patients. Russian eye clinics also use the drops for optic nerve damage and glaucoma, where comparison groups often improved too. [1], [34], [35], [36]

Anxiety, mood and depression

Some people use Semax for low mood or anxiety. [37] Some community education groups also list it for anxiety. The Russian label is more cautious: it lists "neurotic disorders" and work under stress among its uses, but rules Semax out for disorders that come with anxiety. Rat studies found mixed antidepressant-like effects, and no human study has isolated Semax's effect on mood or anxiety; a report in teenagers with depression combined it with therapy. [1], [38], [39]

Other uses you may come across

Small Russian studies looked at stomach ulcers, migraine and motor neuron disease (see human research). Tinnitus, long COVID and head injury appear in personal accounts. Recovery after head injury is a labeled use in Russia, but we found no published human study of it; the other two have not been studied. [40], [41], [1], [42], [43], [44]

Where do Semax protocols differ?

Semax amounts look simple until you notice that people count in drops, sprays, micrograms per nostril and micrograms per day, for three different products. Here is what changes between them and why it matters.

Is the number for one drop, one spray, one dose or the whole day?

The same "3 drops" can differ tenfold. One drop of licensed 0.1% Semax holds 50 mcg and one drop of the 1% holds 500 mcg. Some pages get this wrong: one says a 0.1% drop is about 30 mcg, another says 1–2 drops of 1% are 100–200 mcg (they are 500–1,000 mcg). [1], [2], [25], [45]

Home-made sprays are harder still: 10 mg mixed in 5 mL gives 200 mcg per 0.1 mL pump, the same powder in 10 mL gives 100 mcg, and many pumps are not 0.1 mL. Per-nostril figures trip people up too: 600 mcg per nostril twice a day is 2,400 mcg a day, not the 1,200 mcg one page gives. [12], [46]

The 1% label allows 6,000–20,000 mcg a day in the first days after a stroke, and the Russian stroke studies tested 6–24 mg a day. A stroke result does not show that a 200–600 mcg "focus" dose works, and pages that call the stroke doses injections or drips are wrong: the label and the studies used nose drops. [2], [31], [32], [26]

Three columns comparing amounts. Licensed 0.1% drops: one drop holds 50 mcg, so 3 drops hold 150 mcg. Licensed 1% drops: one drop holds 500 mcg, so 3 drops hold 1,500 mcg. Home-made spray example: one 0.1 mL spray holds 200 mcg if 10 mg is mixed in 5 mL, or 100 mcg if mixed in 10 mL; it depends on the mix and the pump.

The same count, different amounts

Licensed 0.1% drops
1 drop =
50 mcg
3 drops =
150 mcg
Licensed 1% drops
1 drop =
500 mcg
3 drops =
1,500 mcg
Home-made spray (example)

one spray = 0.1 mL

10 mg in 5 mL:
200 mcg per spray
10 mg in 10 mL:
100 mcg per spray

depends on the mix and the pump

“3 drops” or “2 sprays” means nothing without the strength.

The same count means different amounts. A drop of the licensed 0.1% solution holds 50 mcg and a drop of the 1% solution 500 mcg; a home-made spray holds whatever its mix and pump deliver. The spray values are worked examples from a dosing website, not tested doses. Sources: Semax 0.1% label (Vidal) · Semax 1% label (Vidal) · Spray arithmetic example.

Nose drops, nasal spray or injection?

The human studies gave Semax through the nose. Subcutaneous injections are common online and people split on which route they prefer, but there are no human data on injected Semax: no safety study, no blood levels, no dose comparison. Pages that convert between routes are guessing; one gives 750–1,000 mcg by nose but 100–300 mcg by injection. [7], [47], [48]

Morning only, weekdays only or as needed?

Semax is usually taken early in the day because it can disturb sleep; the label's fatigue schedule already says "first half of the day". People also use it on workdays only (5 days on, 2 off), or only on demanding days. None of these patterns has been compared. [1], [17], [49], [50]

How long, and are breaks needed?

Adult label courses are short (3–14 days, 10 for stroke; the children's course is 30 days) and repeated "if necessary"; one long Russian study repeated a monthly course up to six times a year for three years. Websites instead describe cycles such as 10–14 days on and 2–3 off, or 2–4 weeks on and 1–2 off, usually "to prevent tolerance". No study has tested whether breaks do that, and one page's claim that its cycle "is built into Russian clinical protocols" is not supported. [1], [35], [17], [18]

How do micrograms convert to syringe units?

Semax for injection is sold as a powder in a vial that is mixed with sterile water. On a U-100 insulin syringe, units measure volume, not drug. For example, a 5 mg vial (5,000 mcg) mixed with 2.5 mL gives 2,000 mcg per mL, or 20 mcg per unit, so 300 mcg would be 15 units. The same 300 mcg is 30 units if the vial is mixed with 5 mL. Doserly's reconstitution calculator works this out for any vial and shows each step. [13]

What happens when you stop Semax?

No study has looked for withdrawal effects or a rebound, and the FDA notes that Semax's potential for misuse has never been assessed. Most human courses lasted 5–21 days, with outcomes measured during treatment or soon after. [7]

  • How long effects last. In a Russian study of poor brain circulation, benefits were estimated to last 4–6 weeks after a 3-week course, and repeat courses did not build up. In diabetic eye disease, vision gains with nose drops were back to the starting level by six months. [34], [51]
  • Side effects. In a study of stroke and long-term poor brain circulation, about 7% had a cold, pale nasal lining, which settled after a 1–2-day pause and oily nose drops. [35] In one public account, dizziness went away after stopping. [52] In community education groups, people describe irritability, anxiety and poor sleep settling within days of stopping; these are personal reports, not measured recovery times.
  • Focus effects. Some people describe focus dropping on days off or after stopping, others describe benefits lasting days or months, and one found a faded effect did not return after a two-month break. [53], [27], [54]

The label says nothing about stopping or tapering, website claims of "no dependence" have no test behind them, and the breaks websites recommend are a user convention. [1], [17]

Source-by-source comparison of Semax dosing pages

How do the dosing pages compare?

Unit key: 1 milligram (mg) = 1,000 micrograms (mcg). One drop of 0.1% Semax = 50 mcg; one drop of 1% = 500 mcg.

Most nasal pages repeat one of two families. The larger says 200–600 mcg a day, once or split into two or three doses, for about two weeks: Peptide Protocols, PeptideCalcHub, Pep-Tidy, PeptideRadar and Peptides Institute. [14], [3], [15], [16], [11] The other gives 200–600 mcg each time, two or three times a day, which is up to three times more per day: Peptide Protocol Wiki and Peptide Mag; TrimRX gives 300–600 mcg one to three times a day. [55], [13], [21] Pages in both families call their figure the standard dose. [3], [55]

Injection pages cluster at 200–500 mcg a day, usually once but sometimes split (as on PeptideFox): Peptide Mag, Peptides Institute and PeptideFox, with PeptideDosage.org stepping up every two weeks from 200 to 500 mcg by week 7, then holding that to week 12. A clinic chart and Semax Labs go to 1,000 mcg a day. Guide to Peptide gives 100–300 mcg by injection but 750–1,000 mcg by nose. [13], [11], [17], [20], [19], [18], [47]

Which pages contain errors?

Peptide Protocol Wiki says a drop of 0.1% Semax holds about 30 mcg (the label says 50). PeptideWiki says 1–2 drops of 1% are 100–200 mcg (they are 500–1,000). Semax Labs halves its own total when converting per-nostril amounts to a daily figure, and describes the stroke doses as intravenous or intramuscular, although the label and the studies used nose drops. TrimRX gives a precise plasma half-life that has never been measured. [25], [45], [46], [26], [21]

Some pages also borrow numbers from other molecules or misread studies: one gives a chemical formula that belongs to N-acetyl Semax amidate, and another credits a stroke study to the wrong authors. [47], [17]

Where do the website cycles come from?

The label says to repeat a course "if necessary" and gives no break length. Websites add 2–3 days off, 14 days off, 2–4 weeks off, 5 days on and 2 off, or longer breaks after several rounds, usually to "prevent tolerance". One page says its cycle "is built into Russian clinical protocols"; the label does not support that, and no study has compared break lengths. [1], [17], [11], [13], [21]

What are the registered studies planning?

Checked September 23, 2026: searches of ClinicalTrials.gov for "semax", "MEHFPGP" and the Russian name returned no registered studies. [56]

Do nasal drops, sprays and injections behave the same way?

Nobody knows, because Semax has never been measured in human blood by any route. There is no human pharmacokinetics study, so there is no measured bioavailability, peak level or half-life for drops, sprays or injections. [7]

The label says up to 60–70% of a nasal dose is absorbed and that Semax passes quickly into the brain, but no human study measuring either has been published. In rats, about 0.09% of a nasal dose per gram of brain tissue was found in the brain two minutes later, mostly intact; after an injection into a vein, only about 0.005% of the dose reached the brain at its peak. [1], [57], [58], [7]

Grid comparing four forms of Semax. Nasal Semax: studied in people as drops or electrophoresis through the nose; blood levels not measured; in rat studies a small share reaches the brain within minutes; 50 mcg (0.1%) or 500 mcg (1%) per drop; label storage 2 to 8 °C and up to 30 days at or below 25 °C after opening. Home-made nasal spray: not tested in people; blood levels and brain entry not measured; amount depends on the mix and the pump; no stability data. Injection under the skin: no human data; blood levels and brain entry not measured; amount depends on the mix; no stability data. N-acetyl Semax amidate and Adamax: different molecules, not tested in people; nothing measured; amount unknown; no stability data.

What has been measured for each form of Semax

Licensed nose drops

Tested in people
Yes: Russian patient studies (drops, or electrophoresis through the nose)
Blood levels in people
Not measured
Reaches the brain
Rat studies: small share within minutes
Amount per dose
50 mcg (0.1%) or 500 mcg (1%) per drop
Storage tested
Label: 2–8 °C; up to 30 days at ≤25 °C after opening

Home-made nasal spray

Tested in people
No
Blood levels in people
Not measured
Reaches the brain
Not measured
Amount per dose
Depends on the mix and the pump
Storage tested
No stability data

Injection under the skin

Tested in people
No human data
Blood levels in people
Not measured
Reaches the brain
Not measured
Amount per dose
Depends on the mix
Storage tested
No stability data

N-acetyl Semax amidate / Adamax

Tested in people
No (different molecules)
Blood levels in people
Not measured
Reaches the brain
Not measured
Amount per dose
Unknown
Storage tested
No stability data

● measured, tested or on the label◐ animal data only○ not measured or no data

Only nasal Semax (drops or electrophoresis through the nose) has been studied in people, and no form has had its blood levels measured in people.

What has and has not been measured for each form. Only nasal Semax, as drops or by electrophoresis, has been studied in people, and no form has had its blood levels measured in people. Rat studies show fast breakdown and a small, fast rise in the brain after nasal dosing. Sources: FDA briefing document, 2026 · Rat nasal transport study, 2006.

Is a home-made spray the same as the licensed drops?

Not necessarily. The licensed drops are a fixed 0.1% or 1% solution with a preservative (methylparaben) and a stated amount per drop. A home-made spray from a research powder has an unverified amount of peptide, an unknown pump volume and no stability data, and the FDA noted that no Semax spray pump has been tested. [1], [2], [7]

How long does Semax last in the body?

In people, its half-life is unknown. Enzymes break it down fast: in rat blood only about 0.7% was intact after an hour in a laboratory test, and its main breakdown product is the tripeptide Pro-Gly-Pro (PGP). [59], [57], [7]

An older label version and a developer review say one dose acts for 20–24 hours, crediting its breakdown pieces. That is a claimed effect duration, not a blood measurement. Website half-lives, from a few minutes to about half an hour, have no human measurement behind them either. [24], [60], [61], [21]

Is N-acetyl Semax amidate (NASA) or Adamax a stronger Semax?

They are different molecules: N-acetyl Semax amidate ("NASA") has chemical caps on both ends and Adamax has an extra adamantane group, and neither has published human data. Some pages list NASA as another name for Semax or give it smaller doses on the untested assumption that it is stronger. [62], [63], [45]

Is Semax acetate different from Semax?

It is the same peptide as an acetate salt, a common form for peptide powders. The FDA treats the two as separate ingredients, but no study has compared them in people. [7]

How should Semax be stored, and how long does it last?

For the licensed drops, the answer comes from the label. For research powders and home-made sprays, no shelf life for human use has been established.

  • Licensed drops (current 2025 label). Keep at 2–8 °C, away from light, and do not freeze; unopened shelf life is 2 years. Once opened, keep at up to 25 °C for no more than 30 days. Older labels gave no limit after opening, and a manufacturer question-and-answer page says six months; the current label's 30 days is the figure to follow. [9], [10], [22], [64]
  • Research powder. Laboratory suppliers give their own conditions, such as −20 °C for the dry powder; one advises against keeping it dissolved for more than a day, another says 2–7 days at 4 °C. These are statements for laboratory material, not drug labels. [65], [66]
  • Mixed vials and home-made sprays. Dosing websites give about 2–4 weeks in the fridge without citing a Semax stability test; one says its estimate is borrowed from similar peptides. No study has measured how long a home mix keeps its strength. [13], [18]

This guide does not cover mixing or injection technique; the Academy note below covers practical handling.

What do we actually know about Semax in people?

More than for most research peptides, but less than its Russian approval suggests. The human studies are almost all Russian, mostly from the network that developed Semax, and most compared Semax with usual care without random assignment. All gave it through the nose, and none is registered on ClinicalTrials.gov. [7], [56]

Conceptual comparison of cells in a laboratory dish, an animal study notebook, and human study records. Each answers a different research question. A lab finding cannot by itself establish patient benefit.
Cell studies explore biological activity. Animal studies explore effects in another species. Human studies must test outcomes in people with an appropriate design. These are different kinds of evidence, not interchangeable steps to a proven treatment.

What did the stroke studies find?

StudyWhat researchers reportedWhat it cannot establish
Stroke guide, 2011160 patients, described as randomly assigned to placebo or 6, 12 or 18 mg a day for 5 days. Deaths by day 30: 12.5% on placebo versus 7.5%, 5% and 2.5%; good recovery in 75% on 12–18 mg versus 20% on placebo.Developer-edited, not peer-reviewed; its own table gives a different placebo death count, and allocation is not described. [31]
First stroke study, 199730 patients on 12, 18 or 24 mg a day for the first 5 days (a few for 10) versus 80 on usual care; faster recovery of movement.Not randomized. [32]
Meta-analysis, 20183 of 8 Russian studies (181 patients) could be pooled: 12–18 mg a day for 10–14 days lowered stroke severity scores more than comparison care at days 10–21.Small, poorly randomized studies; the authors call for a large blinded trial. [33]
Stroke cohort, 201269 patients on 12 mg a day for 21 days versus 18 controls: symptoms eased within the first week in 83%, and memory scores improved 4–7 days earlier.Not randomized; small control group. [35]
Rehabilitation, 2018110 patients; those given two 10-day courses of 6,000 mcg a day had higher blood BDNF and better daily-activity scores.Allocation not described; group sizes not given. [67]

The FDA judged the stroke evidence "insufficient" but did not review the Russian-language studies because they were not translated. That is a limit of its review, not a finding that those studies were negative; they have design weaknesses of their own. [7]

What about memory problems from poor brain circulation?

  • 2005. 187 patients given 3-week courses, compared with 118 who were not: fewer worsenings, with benefits estimated to last 4–6 weeks after each course. [34]
  • 2012. 120 patients took 0.1% drops three times a day for a month, up to six times a year for three years, compared with 32 who did not; the most affected group gained 2.5 times as much function as controls at one year and 3 times as much at three. [35]

Neither study was randomized, so healthier or more motivated patients may have ended up in the Semax groups.

Eye, ulcer, pain and other studies

  • Optic nerve disease, 2000. 74 patients: 25 given drops, 29 given Semax by electrophoresis through the nose, and 20 on usual care. Vision improved in all three groups, including the comparison group. [36]
  • Glaucoma. A 2012 study of 110 patients does not give clear group sizes. In a 2014 study, 24 people on Semax and 12 on salt-water drops both improved, with a larger gain on Semax in one measure of visual sensitivity; the paper does not say how people were assigned. [68], [69]
  • Peptic ulcer, 2002. Added to standard ulcer drugs for 10 days, 89.5% of ulcers healed by day 14 versus 30.8%; assignment not described. [40]
  • Migraine and nerve pain, 1996. One nasal dose stopped migraine pain in 4 of 12 people; the authors concluded Semax had no pain-relieving effect of its own. [7]
  • Motor neuron disease, 2007. An open study of 27 patients found no effect on the disease. [41]

Has Semax been tested in healthy people?

Only briefly: a 1996 study of 19 men measured alertness and brain waves after 1 mg by nose a day for two days or a single 0.25 mg dose, a scan study compared 14 people given one dose with 10 given placebo, and a second scanned 52 volunteers across Semax, Selank and placebo (its Semax group may be the same people). A larger resting brain network is not the same as better thinking. No study has tested focus, memory or work performance over weeks of use. [7], [29], [70]

How might Semax work?

Nobody knows how Semax works in people. The explanations below come from rat and mouse studies and from cells in a dish, almost all from the developers' network. Rodent doses (typically 50–250 mcg per kilogram by nose) cannot be converted into human doses. [7], [71]

Does Semax raise BDNF?

In rats, yes. One nasal dose of 50 mcg per kilogram raised BDNF (brain-derived neurotrophic factor, a protein that helps nerve cells survive and form connections) in the hippocampus, a memory area, by up to 1.4 times, and increased the activity of its receptor, TrkB. Other rat studies found genes for BDNF and nerve growth factor switched on within an hour. [71], [72], [73]

In people, the only measurement is higher blood BDNF in stroke rehabilitation patients. Nobody has measured brain BDNF in people, and online claims of "BDNF up 300–800%" have no source. [67]

Conceptual illustration of a nerve cell in the hippocampus releasing BDNF, a growth-support protein, which binds TrkB receptors on a neighbouring nerve cell's branches. It represents rat study findings, not a measured effect in a person.
In rats, one nasal dose of Semax raised BDNF in the hippocampus and activated its TrkB receptor. Whether this happens in the human brain has never been measured. This generated illustration explains a concept; it is not microscopy or clinical evidence.

Does it protect the brain after a stroke?

In rat stroke models, Semax reduced the damaged area and changed the activity of hundreds of genes linked to inflammation and nerve signalling. That fits the Russian stroke studies but cannot confirm them. [74], [75]

Does it act like a stimulant?

Partly, in animals. In rodents, Semax did not change dopamine by itself but raised a serotonin breakdown product and made amphetamine's effect on dopamine and movement stronger: mice given both moved about 261% of their baseline, compared with 182% on amphetamine alone. The FDA flags this as a reason Semax's misuse potential should be studied. [76], [77], [7]

Is Semax a hormone? Does it raise cortisol?

It is built from a small part of ACTH, and 1986 animal tests found it did not trigger steroid release. The label calls it "completely devoid of hormonal activity". [8], [1]

The only human study that measured it points the other way. In 60 people with psoriasis and metabolic syndrome given 600 mcg a day for 10 days with standard care, blood cortisol rose by 28.2%, from below the level seen in healthy volunteers toward it, and ACTH fell by 28.9%, compared with 58 on standard care alone. It was not randomized, so it does not prove Semax raised cortisol, but claims that it "lowers cortisol" or works "without triggering stress hormones" are not supported. [78]

Does it affect pain or blood clotting?

In rats, pain results depended on the test, and an enzyme effect in human blood samples needed high laboratory concentrations. Rats given Semax also had more clot-dissolving activity and less platelet clumping, which the FDA says could mean a bleeding risk with blood thinners; this has not been studied in people. [79], [80], [7]

What are the risks and unanswered questions?

Is Semax safe?

Nobody has shown that it is safe outside its licensed use. Its safety record comes only from Semax given through the nose, mostly in short courses, and it is thin: the label lists one side effect, mild nasal irritation, and most studies did not say how they checked for side effects. The FDA found no standard toxicity, genetic-damage, pregnancy or cancer studies, and there are no safety data for injected Semax. [1], [7]

What side effects have been reported?

ProblemWhat was reportedSource
NoseMild irritation with long use (label); pale nasal lining in 10% of stroke patients; a cold, tingling nose in about 7% of patients in one stroke and brain-circulation study, settling after a 1–2-day pauseLabel, Russian studies [1], [31], [35]
Blood sugarA mild, brief rise (no more than 10% above usual) in 7.4% of stroke patients who had diabetes; another study found no changeRussian studies [31], [34]
AllergyLocal allergic reactions in 3 of 187 patients (1.6%); the 1% label warns its preservative, methylparaben, can cause delayed allergy and, rarely, airway spasmRussian study, label [34], [10]
Seizure-like brain activitySeizure-like (paroxysmal) activity in 3 patients recovering from oxygen starvation of the brain, seen on brain-wave recordings in all three and with clinical signs in one, after a large 3 mg nasal dose; it stopped when the dose and method were changedRussian study [81], [82]
Eye painOne FDA database report: eye pain and burning after online-bought 0.1% drops, with a hospital stay; cause not establishedRegulator database [7]

People using research sprays and injections also describe poor sleep, irritability, anxiety, headaches and a feeling of emotional flatness; those accounts are covered in what people report.

Can Semax cause seizures?

It might in people prone to them, and the label rules it out for anyone with a seizure history. In patients recovering from oxygen starvation of the brain, seizure-like activity appeared only after a large single dose, and the authors advised a brain-wave check when treatment starts; in animals, results were mixed. [1], [81], [82], [83] Some community education groups list Semax for "seizure recovery", which contradicts the label.

Does Semax cause hair loss?

No study has looked. Some people online describe shedding or bald patches, one with regrowth after stopping, while others say their hair was unaffected; none of these accounts can show cause, and the proposed link through cortisol is unproven. [84], [53], [54]

Is Semax addictive?

This has not been studied. The FDA says Semax's potential for misuse has not been assessed, and points to rodent studies in which Semax strengthened amphetamine's effect on dopamine and movement. No published report describes withdrawal or dependence, but no study was designed to find it. [7], [77]

Could product quality change the risk?

Yes. The licensed drops are made under Russian drug rules; research powders and sprays are not. The FDA noted no data on impurities, clumping (aggregation) or bacterial toxins for compounded Semax, and that injected or sprayed peptides may trigger immune reactions. Belgian laboratories confirmed Semax in a seized vial but did not test its purity. [7], [85]

Is Semax legal? Is it FDA-approved?

Checked September 23, 2026. Rules differ by country and change quickly. A "research use only" label does not make a product legal to sell or safe to use.

United States. Semax is not an FDA-approved medicine. The key steps:

  • Nominations withdrawn. Two companies asked the FDA to let pharmacies compound Semax, then withdrew. The FDA's list of compounding ingredients with safety concerns shows it as "nominated but withdrawn", warning of possible immune reactions and limited safety information. [7], [86]
  • 2026 staff review. The FDA reviewed Semax for brain ischemia, migraine and trigeminal neuralgia, found the evidence insufficient and recommended against compounding. [7]
  • July 24, 2026. Its Pharmacy Compounding Advisory Committee voted 8 to 5, with 1 abstaining, to recommend adding Semax, as both the free base and the acetate salt, to the list of bulk ingredients pharmacies may compound. An advisory vote is not an FDA decision. [87], [88]
  • Now. No final decision had been published by September 23, 2026, and Semax is not on the list of bulk ingredients US pharmacies may use. [89], [90], [91]

Canada. Health Canada named Semax in an August 2025 advisory about seized unauthorized injectable peptides, and we found no Canadian authorization. [92]

Australia. Semax is not named in the June 2026 Poisons Standard, and we found no Australian approval or regulator statement naming it. A missing name does not make it legal to sell or import. [93]

United Kingdom and Europe. We found no UK or European Union authorization for Semax and no regulator statement naming it, as of September 2026.

Russia and Ukraine. In Russia, the 0.1% and 1% drops are prescription medicines, registered again in 2025 and on the official list of essential medicines. A Ukrainian registration expired in 2014, so pages calling it approved there are out of date. [1], [2], [94], [95]

Is Semax banned in sport? Does it show up on a drug test?

It is not named on the World Anti-Doping Agency's 2026 or 2027 lists. Their S0 rule bans substances with no current approval by any government health authority; because Semax is approved in Russia, it is unclear whether S0 covers it, and we found no athlete case. Competitive athletes should check with their anti-doping organization. We found no published test for Semax in urine or blood, although laboratories can identify it in products. [96], [97], [85]

Who should be especially cautious?

The label rules out the first four groups. The others are cautions from studies or have not been studied, which is a reason for caution, not proof of harm.

  • Anxiety disorders. Ruled out by the label, and anxiety and irritability are common complaints online. [1]
  • A history of seizures, psychosis or acute psychiatric illness. [1], [81]
  • Pregnancy and breastfeeding. No studies were done. [1]
  • Children and teenagers. The 1% drops are for adults only. The 0.1% label allows one children's use from age 7 but rules out under-18s for eye and brain-surgery uses, and the children's ADHD listing rests on a small comparison known only from a secondhand summary. [1], [2], [30]
  • Diabetes, because of the blood-sugar rise; the stroke guide advises caution in poorly controlled diabetes. [31]
  • Blood thinners, because of the rat clotting findings. [7]
  • Stimulants, antidepressants or mood stabilisers. Interactions are unstudied, and Semax strengthened amphetamine's effects in rodents. [77] In community education groups, some people describe cutting or stopping these medicines when starting Semax, often without their prescriber; changes to a prescribed medicine belong with the prescriber.
  • Paraben allergy, for the 1% drops' preservative warning. [10]
  • Drug-tested athletes, because of the S0 rule. [97]

Has Semax been tested alongside other medicines?

Not in a formal interaction study. Several Russian studies gave Semax alongside standard treatments, but none tested interactions with specific medicines. The label's only interaction advice is to avoid decongestant nose drops (the kind that narrow blood vessels) at the same time, the FDA's stimulant and blood-thinner concerns come from animal studies, and nothing is known about Semax with antidepressants, ADHD medicines, alcohol or Selank. Bring a complete list of everything you take to a pharmacist or doctor. [1], [7], [77]

What should be monitored while using Semax?

The Russian label sets no blood tests or check-ups. What exists is a record of what the studies measured and what they found, which can help you prepare questions for a clinician; it is not a personal testing plan.

What does the label ask for?

No routine blood tests or check-ups. The labels list the conditions in which Semax should not be used and advise against decongestant nose drops at the same time; the 1% label also warns that its preservative can cause allergic reactions and, rarely, airway tightening. Neither label has driving-study data. The 1% drops are meant for acute stroke as part of combined treatment. [9], [10]

What did the human studies check?

  • The 2011 stroke guide measured blood pressure, pulse, heart tracings (ECG), blood chemistry, blood sugar and brain waves (EEG) for 30 days; blood pressure and ECG did not change meaningfully. [31]
  • The 2005 circulation study checked brain waves, ECG, blood counts, blood sugar and cholesterol; blood sugar and brain waves did not change. [34]
  • The posthypoxic studies recorded brain waves in patients recovering from oxygen starvation of the brain; three had seizure-like activity after a 3 mg nasal dose, and the authors advised an EEG at the first dose. The psoriasis study found cortisol higher and ACTH lower. [81], [82], [78]

Which signals matter, and why?

A seizure or a severe allergic reaction needs urgent medical care rather than tracking. [81], [10]

Why it mattersWhat studies, labels or reports flaggedTracking category
SleepLabel schedules keep doses to the first half of the day, and poor sleep is a common complaint online [1], [98]Sleep Quality
Anxiety, irritability and moodAnxiety disorders are a label contraindication; irritability and emotional flatness in personal accounts [1], [98], [99]Anxiety; Emotional Regulation; Mood & Wellbeing
Focus and memoryEasy to misjudge without a record; one account describes worse word-finding after about two weeks of use [100]Focus & Mental Clarity; Memory & Cognition
Blood sugarA small rise in some stroke patients with diabetes [31]Blood work
Stress hormonesCortisol rose in the one human study that measured it [78]Blood work; Stress Tolerance
NoseIrritation, pallor or a cold feeling [1], [35]Side Effect Burden
Headache, dizziness, hairCommon in personal accounts; hair shedding unstudied [52], [84]Side Effect Burden; Hair Health

These come from small studies and personal accounts, so they show what has been flagged, not what a person will experience.

What do people in public communities report?

Public forums, Russian review sites and community education groups contain enthusiastic reports, flat disappointments and a steady stream of sleep and mood complaints, often in the same thread. Most people online use research sprays or injections, not the licensed drops, and most take other things too. These are selected discussions, not a survey of everyone who has tried Semax.

What do the positive reports look like?

The typical success story is a short lift in focus and drive, with less brain fog and easier word-finding. One person on 400 mcg twice a day for two weeks described sharper recall but also emotional blunting and worse sleep; another, after years of on-and-off use, took 250 mcg with Selank every morning for one to two months and credited it with better ADHD symptom control. [98], [27]

Accounts from people using the licensed drops are more mixed: one described longer focus but feeling spacey and less social; a caregiver saw no memory benefit in an elderly parent after two years of two-week courses. [99], [101]

How fast does it work, and how long does it last?

Nasal users describe an effect within minutes that fades after a few hours; injection users describe a slower, milder, longer effect, a pattern that recurs in community education groups. People split on which route they prefer, and several found one route did nothing while the other worked. [102], [103], [104]

Does everyone notice something?

No, and "nothing happened" is one of the most common stories: one person noticed nothing at 500 mcg a day, another after five days of injecting 500 mcg each of Semax and Selank, and another after up to 10 drops at a time. The explanations offered (wrong route, too little per spray, a poor batch, a healthy brain having little to gain) are untested. [50], [103], [105], [106] In community education groups, nonresponders appear on both routes and at every dose.

What unwanted effects come up?

The recurring complaints are poor sleep when dosed late, irritability, anxiety, headaches and an afternoon slump. Less common reports include emotional blunting, worse word-finding after a couple of weeks, dizziness, hair shedding and a fainting episode in an overheated classroom. Russian reviewers of the licensed drops described severe headaches, confusion and trouble reading after the first doses. [98], [100], [52], [84], [107], [108] In community education groups, these complaints cluster at higher or quickly raised doses and settle within days of stopping.

Does it stop working over time?

Some say it does. One described a strong early effect that faded over months and did not return after a two-month break; another suspected rising tolerance after two months of weekday use. Others describe steady effects across cycles. [54], [49], [48] In one community education group account, a faded effect returned after a two-week break. No study has tested tolerance.

How can you judge a Semax story?

Ask: Was it the licensed drops, a home-made spray, an injection, or N-acetyl Semax amidate sold under the same name? How many micrograms, rather than "sprays" or "units"? What else changed: Selank, caffeine, ADHD medicine, antidepressants, sleep, work? Was anything measured, or only felt? Did the person post again weeks later? Focus is where expectation matters most, and one good day proves little.

How does Semax compare with Selank, Dihexa and Pinealon?

These peptides are sold side by side as "brain" peptides and often stacked. Of the four, only Semax and Selank are registered medicines, both in Russia.

PeptideWhat it isHow it is takenHuman evidenceApproval status
Semax (this guide)Seven amino acids from an ACTH fragment [7]0.1% nose drops, 2–3 drops per nostril 2–4 times a day for 3–14 days, depending on the use (label) [1]Small Russian patient studies, mostly not randomized [31], [34]Prescription medicine in Russia; not FDA-approved [1], [7]
SelankA different seven-amino-acid peptide based on tuftsin, an immune-system peptide; shares Semax's last three [80], [109]0.15% nose drops, 2 drops per nostril 3 times a day for 14 days (label) [109]Small Russian comparisons with anxiety medicines [110]Non-prescription anxiety medicine in Russia; not FDA-approved [111], [86]
DihexaA small lab-made molecule derived from angiotensin IV [112]Research chemical; no tested human dose [86]None for Dihexa itself found by the FDA (its guide covers trials of an injected prodrug); a key mechanism paper was retracted in 2025 [86], [113]Not FDA-approved; no approval found elsewhere [86]
PinealonThree amino acids (Glu-Asp-Arg) [114]Research product; no tested human doseRussian reports combined it with another peptide [115]No approval found; named in a Canadian seizure advisory [92]

Semax and Selank are Russian medicines with small Russian studies behind them; Dihexa and Pinealon have no approved use and little or no human research. The only direct comparison is a brain-scan study of 52 healthy people given Semax, Selank or placebo, which did not test symptoms or safety, so the table cannot say which works better or is safer. [70]

Semax and Selank are made by the same Russian company and are often combined, Semax in the morning for focus and Selank in the evening for calm, or mixed in one spray. That combination has never been studied, and in a mixed spray the amount of each per press depends on how it was made. [111], [27]

Common questions about Semax

How long does Semax take to work?

People who notice an effect usually describe it within half an hour of a nasal dose, more slowly after an injection; many notice nothing. The stroke studies measured recovery over days to weeks. [102], [50], [35] See what people report.

Is Semax a stimulant? Is it like Adderall?

Not in the usual sense: it did not raise dopamine by itself in animal studies, though it strengthened amphetamine's effect. Many people describe it as activating, with better focus and sometimes poor sleep or irritability. It has never been compared with ADHD medicines. [76], [77], [98] See how it might work.

Can Semax replace ADHD medication or an antidepressant?

There is no evidence that it can. The label's ADHD listing for children rests on a small 2000 comparison known only from a review's summary, in which Semax did about as well as piracetam, and Semax has never been tested in adults with ADHD or depression. Any change to a prescribed medicine belongs with the prescriber. [30], [7] See who should be cautious.

Is Semax the same as Selank? What is the Semax and Selank stack?

No. Selank is a different seven-amino-acid peptide, sold in Russia as non-prescription anxiety drops, that shares only Semax's last three amino acids. The "stack" usually means Semax in the morning and Selank in the evening, or both in one spray; the combination has not been studied. [80], [111], [27] See how they compare and the Selank guide.

Does Semax raise or lower cortisol?

The only human measurement found cortisol 28% higher after 10 days, rising from below-normal levels, in a non-randomized study of people with psoriasis on other treatment. That does not prove Semax raises cortisol, but claims that it lowers it are not supported. [78] See the hormone question.

Is Semax approved in Russia? Is it legal to buy?

It is a prescription medicine in Russia, as nose drops. It is not FDA-approved or on the federal list of bulk ingredients US pharmacies may use for compounding, and we found no approval in Canada, Australia, the United Kingdom or the European Union. The Russian approval covers the licensed drops, not research sprays or injections, and a "research use only" label does not make a product legal to sell. [1], [7], [89] See the dated legal-status summary.

Can you take Semax every day, long term?

Long-term daily use has not been studied. Adult label courses last 3–14 days (the children's course is 30 days) and are repeated when needed; the longest study repeated monthly courses up to six times a year for three years. Weekday-only and cycled schedules online are conventions, not tested plans. [1], [35], [17] See where protocols differ.

Glossary

Plain explanations of the route, dosing, brain and research terms used in this guide. Underlined terms in the text link here.

ACTH
Adrenocorticotropic hormone, a pituitary hormone that tells the adrenal glands to release cortisol. Semax is built from a small piece of it that lacks this hormone effect in animal tests.
Adverse event
A harmful or unwanted medical event reported after someone used a treatment. A report alone does not prove the treatment caused it.
Aggregation
Peptide molecules clumping together. Clumps can make a product weaker and, when injected, more likely to trigger an immune reaction.
Amino acid
A small chemical building block. Chains of amino acids make up peptides and proteins.
Animal study
Research in animals such as rats or mice. It shows what a substance does in a living body, but results in people can differ.
BDNF
Brain-derived neurotrophic factor, a protein that helps nerve cells survive, grow and form connections. It works through a receptor called TrkB.
Bioavailability
How much of a dose reaches the bloodstream in a usable form. It depends heavily on the route.
Cell study (in vitro)
Research on cells grown in a dish. It gives early clues about biology, but it is far from proof of benefit in people.
Compounding
When a pharmacy prepares a customized medicine from individual ingredients. In the US, federal lists control which bulk ingredients pharmacies may use.
Controlled trial
A study that compares people who receive a treatment with a similar group who do not, often receiving a placebo instead. Randomly assigning people to each group makes the comparison fairer.
Course and cycle
A course is the period of repeated use, such as 10 days. A cycle is a course plus a planned break before any further use.
Daily total
All the amounts given in one day, added together. For example, 250 mcg twice daily is a 500 mcg daily total.
Dose (amount each time)
The amount given on one occasion. A protocol lists both the dose and how often it is given.
ECG
Electrocardiogram, a recording of the heart's electrical activity taken with pads on the skin.
EEG
Electroencephalogram, a recording of the brain's electrical activity (brain waves) taken with sensors on the scalp.
Half-life
The time it takes for the measured level of a substance in the blood to fall by half. It is not the same as how long an effect lasts.
Intranasal
Given into the nose, as drops or a spray, to be absorbed through its lining. The licensed Semax drops are intranasal.
Investigational
Still being studied and not approved by a regulator, such as the FDA, to treat any condition.
Freeze-dried (lyophilized)
Dried by freezing and removing the water, leaving a powder. Research Semax is sold this way and mixed with liquid before use.
mcg and mg
Micrograms and milligrams. 1 mg equals 1,000 mcg. One drop of 0.1% Semax holds 50 mcg; one drop of 1% Semax holds 500 mcg.
Nootropic
A substance taken in the hope of improving thinking, focus or memory. The word describes how a product is used or marketed, not proof that it works.
Peptide
A short chain of amino acids. Semax is a chain of seven.
Pharmacokinetics
How the body absorbs, moves, breaks down and removes a substance.
Placebo
A dummy treatment with no active ingredient, used as a comparison in studies.
Preclinical research
Studies done before research in people: cell studies and animal studies.
Reconstitution
Mixing a freeze-dried powder with a liquid so it can be measured. The amount of peptide in the vial and the volume of liquid added together set how much each unit or spray holds.
Registered medicine
A medicine a country's regulator has approved for sale for specific uses, with an official label. Semax is registered in Russia, not in the United States or the European Union.
Research use only
A label on products sold for laboratory research. It does not mean a product is approved, tested for human use or legal to sell as a medicine.
Subcutaneous (SC)
Injected into the fatty layer just under the skin. Many online Semax users inject this way, although no human study has tested it.
Syringe units
Markings on an insulin syringe that measure volume. On a U-100 syringe, 100 units equal 1 mL. The amount of drug per unit depends on the vial's concentration.
Titration
Adjusting a dose in steps, usually starting lower and increasing if needed.
WADA
The World Anti-Doping Agency, which publishes the list of substances banned in sport.
Withdrawal and rebound
Withdrawal effects are symptoms caused by stopping a substance. A rebound is a problem returning worse than before after stopping. Neither has been studied for Semax in people.

Explore more of the research

Go deeper into the animal and laboratory experiments behind the mechanism claims.

Across this guide, the citations include 43 original scientific papers: 19 human studies and 24 cell, animal and laboratory studies. The optional library below summarizes selected animal and cell papers by question. Paper counts are not counts of independent research teams: most Semax papers come from one Moscow research network.

In the route details, intraperitoneal means into the abdominal cavity and intravenous means into a vein.

Brain growth signals in rats · 4 papers
  • BDNF and TrkB in the hippocampus. One nasal dose of 50 mcg/kg in rats raised BDNF protein up to 1.4-fold and TrkB activation 1.6-fold, and improved a learned avoidance task. [71]
  • Binding in the basal forebrain. Semax bound specifically to rat forebrain membranes and raised BDNF there after nasal doses of 50–250 mcg/kg, but not in the cerebellum. [72]
  • Growth-factor genes within an hour. After 50 mcg/kg by nose, genes for BDNF and nerve growth factor were more active in the rat hippocampus within an hour. [73]
  • Nerve cells in a dish. In cultured rat nerve cells, Semax improved survival under glutamate toxicity by about 30%, at laboratory concentrations far above anything measured in the body. [116]
Stroke and brain-injury models · 5 papers
  • Smaller damaged areas. In rats with a light-induced stroke in the frontal cortex, nasal Semax reduced the damaged area and memory problems. [74]
  • Immune and blood-vessel genes. After a blocked artery in rats, Semax given into the abdomen (100 mcg/kg) changed the activity of 96 genes at 3 hours and 68 at 24 hours, many linked to immune and blood-vessel pathways. [117]
  • Hundreds of genes after reperfusion. In rats whose blocked artery was reopened, 394 genes differed between Semax and salt water at 24 hours. [75]
  • Growth-factor genes after ischemia. Semax increased BDNF and related receptor genes three hours after a stroke in rats. [118]
  • The breakdown product alone. PGP, Semax's main breakdown product, did not protect brain tissue in the same kind of test, unlike Semax itself. [119]
Mood, stress, dopamine and other animal findings · 6 papers
  • Stress and mood. In male rats under chronic unpredictable stress, Semax eased loss of pleasure-seeking and adrenal enlargement, but did not change a standard antidepressant test (forced swimming). [38]
  • Dopamine and serotonin. In rodents, Semax did not change dopamine by itself but raised a serotonin breakdown product and strengthened amphetamine's dopamine and movement effects. [76], [77]
  • Pain. In rats, Semax increased sensitivity in a heat test but reduced pain responses in others. [79]
  • Seizures. Protective in one rat seizure model; lowered the threshold in another. Early-life exposure in mice changed later seizure susceptibility depending on the strain. [83], [120]
  • Tumour-bearing mice. In female mice that already had breast tumours, Semax (3 mg/kg into the abdomen, five days a week) was linked to longer survival and smaller tumours. This was not a test of whether Semax can cause cancer, and the FDA said so. [121], [7]
  • Parkinson's-type damage. In rats given a toxin that damages dopamine cells, nasal Semax reduced movement and anxiety-related problems. [122]

How this guide was researched

This guide is built from a thorough review of the sources cited throughout it: published scientific studies, official Russian product labels, regulatory documents and published protocol descriptions. We also reviewed public online forums, Russian review sites and community education groups where people describe their own experiences with Semax.

The guide cites 122 sources, including 43 original scientific papers. Each type of source answers a different question. Studies show what researchers measured. Labels show how the licensed product is meant to be used. Protocol descriptions show how Semax is typically used online. Personal accounts show what individual people experienced. Every numbered citation links to its entry below, labeled by source type.

How this guide was made

Research and drafting were AI-assisted. Every cited source was checked against the original, and the guide was reviewed and edited by Doserly before publication. It has not had an independent clinical review, and Doserly does not currently have medical reviewers. Doserly makes a medication and health-tracking app and runs Doserly Academy, both of which are promoted in this guide. Read our editorial policy for how guides are researched, updated and corrected.

This guide is for educational purposes. It summarizes what the reviewed sources report so the research is easier to understand; it is not medical advice. For a deeper dive, or to check any point for yourself, go straight to the cited sources.

Explore the sources

These are the documents cited in this guide. Studies, product labels, website advice and personal accounts answer different questions. A source being listed does not mean every statement on its page is endorsed.

Showing 122 sources

  1. 01

    Semax 0.1% nasal drops (Семакс, капли назальные 0.1%): drug reference entry ↗

    Official product label

    Full entry reviewed in Russian: dosing by use, contraindications, side effects. Reproduces the official instructions.

  2. 02

    Semax 1% nasal drops (Семакс, капли назальные 1%): drug reference entry ↗

    Official product label

    Full entry reviewed in Russian: stroke dosing, contraindications (under 18, pregnancy, anxiety disorders, seizures).

  3. 03

    Semax dosage: intranasal protocols and dilution math ↗

    Dosing website

    Original page reviewed 23 Sep 2026. Describes practice; not clinical validation.

  4. 04

    Heptapeptide as a long-acting memory stimulant (patent SU939440A1) ↗

    Patent

    Original patent record reviewed in Russian.

  5. 05

    Nootropic agent and pharmaceutical composition with nootropic action (patent RU2045958C1) ↗

    Patent

    Original patent record reviewed in Russian.

  6. 06

    History of Semax ↗

    Manufacturer history page

    Original page reviewed in Russian; source of the 1994 first-registration date.

  7. 07

    FDA briefing document: Semax-related bulk drug substances ↗

    Regulatory source

    Full document reviewed: identity, human studies reviewed by the FDA, safety concerns and the staff recommendation.

  8. 08

    Hormonal activity of the ACTH(4-10) analog--a prolonged-action stimulant of learning ↗

    Animal study

    Original abstract reviewed.

  9. 09

    Semax 0.1%: instructions for use (2025 registration) ↗

    Official product label

    Full text reviewed in Russian: storage (2–8 °C; 30 days at up to 25 °C after opening), contraindications, driving.

  10. 10

    Semax 1%: instructions for use (2025 registration) ↗

    Official product label

    Full text reviewed in Russian: storage, methylparaben allergy warning, contraindications, driving.

  11. 11

    Semax: Research Profile & Guide ↗

    Dosing website

    Original page reviewed 23 Sep 2026. Describes practice; not clinical validation.

  12. 12

    Semax Dosage (10 mg Vial) Protocol ↗

    Dosing website

    Original page reviewed 23 Sep 2026. Describes practice; not clinical validation.

  13. 13

    Semax: Dosing & Research Guide ↗

    Dosing website

    Original page reviewed 23 Sep 2026. Describes practice; not clinical validation.

  14. 14

    Semax: Benefits, Dosage & Nasal Spray Guide ↗

    Dosing website

    Original page reviewed 23 Sep 2026. Describes practice; not clinical validation.

  15. 15

    Semax Dosing, Reconstitution & Research Guide ↗

    Dosing website

    Original page reviewed 23 Sep 2026. Describes practice; not clinical validation.

  16. 16

    Semax intranasal dosing: published protocols, 0.1% vs 1% ↗

    Dosing website

    Original page reviewed 23 Sep 2026. Describes practice; not clinical validation.

  17. 17

    Semax Dosage and Research ↗

    Dosing website

    Original page reviewed 23 Sep 2026. Describes practice; not clinical validation.

  18. 18

    How to inject Semax: subcutaneous and intramuscular protocols ↗

    Dosing website

    Original page reviewed 23 Sep 2026. Describes practice; not clinical validation.

  19. 19

    Peptide Dosing Guide: Semax ↗

    Clinic dosing chart

    Original page reviewed 23 Sep 2026. Describes practice; not clinical validation.

  20. 20

    Semax Dosage Chart, Schedule & Reconstitution Protocol ↗

    Dosing website

    Original page reviewed 23 Sep 2026. Describes practice; not clinical validation.

  21. 21

    Semax Dosing Protocol: Cycling, Frequency & Best Practices ↗

    Dosing website

    Original page reviewed 23 Sep 2026. Describes practice; not clinical validation.

  22. 22

    Semax 0.1% nasal drops: instructions for use (2011 version) ↗

    Official product label

    Full manufacturer PDF reviewed in Russian; earlier storage wording (not above 10 °C).

  23. 23

    Semax 1% nasal drops: instructions for use (2011 version) ↗

    Official product label

    Full manufacturer PDF reviewed in Russian.

  24. 24

    Semax: instructions for use (2008 version, reproduced online) ↗

    Official product label

    Full text reviewed in Russian. Superseded: gives 500–5,000 mcg a day and a lower minimum age.

  25. 25

    Semax Dosing Protocols and Administration ↗

    Dosing website

    Original page reviewed 23 Sep 2026. Describes practice; not clinical validation.

  26. 26

    How many mg of Semax a day: dosing protocols and clinical evidence ↗

    Dosing website

    Original page reviewed 23 Sep 2026. Describes practice; not clinical validation.

  27. 27

    Selank/Semax IN experiences ↗

    Public community

    Archived post and replies reviewed. Personal accounts, not clinical outcomes.

  28. 28

    How Semax & Selank completely turned my ADHD symptoms around (and an unexpected 14-point IQ jump) ↗

    Public community

    Archived post and replies reviewed. Personal accounts, not clinical outcomes.

  29. 29

    Effects of Semax on the Default Mode Network of the Brain ↗

    Human study

    Original abstract reviewed.

  30. 30

    Peptide preparation for intranasal administration in pediatrics and psychoneurology ↗

    Review

    Full text reviewed in Russian; summarizes older reports that could not be retrieved.

  31. 31

    Semax in ischemic stroke: methodological guidance ↗

    Human study (developer guide)

    Full text reviewed in Russian. Four arms of 40 described as randomized; allocation not described, internal inconsistency in the placebo figures, not peer-reviewed.

  32. 32

    Usage of neurospecific peptide substance Semax in acute period of ischemic insult ↗

    Human study (not randomized)

    Full text reviewed in Russian: 30 patients on 12, 18 or 24 mg a day versus 80 controls. The same patient group is summarized in PubMed record 11517472.

  33. 33

    Efficacy of Semax in the acute period of ischemic stroke: a meta-analysis ↗

    Meta-analysis

    Full text reviewed in Russian: 3 of 8 screened studies (181 patients) pooled.

  34. 34

    Semax in prevention of disease progress and development of exacerbations in patients with cerebrovascular insufficiency ↗

    Human study (not randomized)

    Full text reviewed in Russian (manufacturer-hosted copy; PubMed record 15792140).

  35. 35

    Semax in acute stroke and chronic cerebral ischemia ↗

    Human study (not randomized)

    Full text reviewed in Russian.

  36. 36

    Evaluation of therapeutic effect of new Russian drug semax in optic nerve disease ↗

    Human study (not randomized)

    Full text reviewed in Russian (manufacturer-hosted copy; PubMed record 10741256).

  37. 37

    I took Semax for a week to treat my anhedonia, anxiety and dysthymia. It's changing my life. Here's my log of each day's experiences. ↗

    Public community

    Archived post and replies reviewed. Personal accounts, not clinical outcomes.

  38. 38

    Antidepressant-like and antistress effects of the ACTH(4-10) synthetic analogs Semax and Melanotan II on male rats in a model of chronic unpredictable stress ↗

    Animal study

    Original abstract reviewed.

  39. 39

    Some questions of therapy of vegetative disorders in children and adolescents with depression ↗

    Human study

    Selected original full-text sections reviewed.

  40. 40

    Therapy of peptic ulcer with semax peptide ↗

    Human study

    Original abstract reviewed.

  41. 41

    The study of chronic partial denervation and quality of life in patients with motor neuron disease treated with semax ↗

    Human study (open-label)

    Selected original full-text sections reviewed.

  42. 42

    Semax for tinnitus ↗

    Public community

    Archived post and replies reviewed. Personal accounts, not clinical outcomes.

  43. 43

    Took a different route ↗

    Public community

    Archived post and replies reviewed. Personal accounts, not clinical outcomes.

  44. 44

    Semax nasal spray life changing have my memory back ↗

    Public community

    Archived post and replies reviewed. Personal accounts, not clinical outcomes.

  45. 45

    Semax Dosage Guide: Nootropic Protocols ↗

    Dosing website

    Original page reviewed 23 Sep 2026. Describes practice; not clinical validation.

  46. 46

    How to take Semax peptide: nasal spray dosing and administration ↗

    Dosing website

    Original page reviewed 23 Sep 2026. Describes practice; not clinical validation.

  47. 47

    Semax: Complete Guide to the Russian Nootropic Peptide ↗

    Dosing website

    Original page reviewed 23 Sep 2026. Describes practice; not clinical validation.

  48. 48

    My Semax Experience: Injectable vs Nasal ↗

    Public community

    Archived post and replies reviewed. Personal accounts, not clinical outcomes.

  49. 49

    Semax long term use? ↗

    Public community

    Archived post and replies reviewed. Personal accounts, not clinical outcomes.

  50. 50

    Anybody have any updates on using semax and how long it takes to work? ↗

    Public community

    Archived post and replies reviewed. Personal accounts, not clinical outcomes.

  51. 51

    Neuroprotective drugs in restorative treatment of patients with diabetic retinopathy ↗

    Human study

    Full text reviewed in Russian; follow-up to 12 months.

  52. 52

    Not even exaggerating, Semax is the greatest thing I have ever taken ↗

    Public community

    Archived post and replies reviewed. Personal accounts, not clinical outcomes.

  53. 53

    Long term effects of Semax? Experiences? ↗

    Public community

    Archived post and replies reviewed. Personal accounts, not clinical outcomes.

  54. 54

    Semax not working anymore, help. ↗

    Public community

    Archived post and replies reviewed. Personal accounts, not clinical outcomes.

  55. 55

    Semax Dosing Calculator ↗

    Dosing website

    Original page reviewed 23 Sep 2026. Describes practice; not clinical validation.

  56. 56

    ClinicalTrials.gov search: semax, MEHFPGP and Семакс ↗

    Study registry search

    All three searches returned no registered Semax studies.

  57. 57

    Kinetics of Semax penetration into the brain and blood of rats after its intranasal administration ↗

    Animal study

    Indexed summary reviewed; the full original could not be opened.

  58. 58

    Entry of the synthetic ACTH(4-10) analogue into the rat brain following intravenous injection ↗

    Animal study

    Original abstract reviewed.

  59. 59

    Prospects of Intranasal Delivery of Neuropeptides to the Brain ↗

    Review

    Full text reviewed; reports laboratory breakdown rates in rat and nasal enzyme preparations.

  60. 60

    A nootropic adrenocorticotropin analog 4-10-semax (l5 years experience in its design and study) ↗

    Review (developer group)

    Original abstract reviewed.

  61. 61

    Semax Dosage Calculator ↗

    Dosing website

    Original page reviewed 23 Sep 2026. Describes practice; not clinical validation.

  62. 62

    N-acetyl semax amidate ↗

    Chemical database

    Compound record checked; a different molecule from Semax.

  63. 63

    Semax — dosing, reconstitution and evidence ↗

    Dosing website

    Original page reviewed 23 Sep 2026. Describes practice; not clinical validation.

  64. 64

    Storage (manufacturer questions and answers) ↗

    Manufacturer page

    Original page reviewed in Russian; its six-month figure conflicts with the 2025 label.

  65. 65

    Semax, Item No. 27719 ↗

    Supplier specification

    Selected original full-text sections reviewed.

  66. 66

    Semax ↗

    Supplier specification

    Selected original full-text sections reviewed.

  67. 67

    The efficacy of semax in the tretament of patients at different stages of ischemic stroke ↗

    Human study

    Original abstract reviewed.

  68. 68

    Semax in treatment of glaucomatous optic neuropathy ↗

    Human study

    Full text reviewed in Russian; group sizes for the placebo phase are unclear.

  69. 69

    Results of a study of the neuroprotective efficacy of Semax ↗

    Human study

    Full text reviewed in Russian.

  70. 70

    Functional Connectomic Approach to Studying Selank and Semax Effects ↗

    Human study

    Original abstract reviewed.

  71. 71

    Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus ↗

    Animal study

    Original abstract reviewed.

  72. 72
  73. 73

    Neurotrophin gene expression in rat brain under the action of Semax, an analogue of ACTH 4-10 ↗

    Animal study

    Original abstract reviewed.

  74. 74

    Neuroprotective and antiamnesic effects of Semax during experimental ischemic infarction of the cerebral cortex ↗

    Animal study

    Original abstract reviewed.

  75. 75

    Novel Insights into the Protective Properties of ACTH(4-7)PGP (Semax) Peptide at the Transcriptome Level Following Cerebral Ischaemia-Reperfusion in Rats ↗

    Animal study

    Original abstract reviewed.

  76. 76

    Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents ↗

    Animal study

    Original abstract reviewed.

  77. 77
  78. 78

    Features of endocrine function in psoriasis associated with metabolic syndrome ↗

    Human study (not randomized)

    Full text reviewed in Russian: 600 mcg a day for 10 days with standard care; cortisol +28.2%, ACTH −28.9%.

  79. 79

    Peptide ACTH4-7-PGP: Effects on Various Types of Pain and Pain-Induced Behavior in Rats after Systemic and Central Administration ↗

    Animal study

    Original abstract reviewed.

  80. 80

    Semax and selank inhibit the enkephalin-degrading enzymes from human serum] ↗

    Cell study

    Original abstract reviewed.

  81. 81

    Prevention and correction of paroxysmal states in patients with posthypoxic encephalopathy (dissertation) ↗

    Human study (dissertation)

    Dissertation summary reviewed in Russian: seizure-like EEG activity in 3 patients after a 3 mg intranasal dose.

  82. 82

    Use of semax at a follow-up of patients with posthypoxic encephalopathy ↗

    Human study

    Original abstract reviewed.

  83. 83

    Anticonvulsive properties of peptide ACTH4-7 pro-gly-pro detected in amygdaloid kindling and audiogenic epilepsy in rats ↗

    Animal study

    Original abstract reviewed.

  84. 84

    Semax hair loss experiences? ↗

    Public community

    Archived post and replies reviewed. Personal accounts, not clinical outcomes.

  85. 85

    The occurrence of putative cognitive enhancing research peptides in seized pharmaceutical preparations: An incentive for controlling agencies to prepare for future encounters of the kind ↗

    Laboratory analysis

    Selected original full-text sections reviewed.

  86. 86

    Certain bulk drug substances for use in compounding that may present significant safety risks ↗

    Regulatory source

    Official page checked; Semax (heptapeptide), Selank acetate and dihexa acetate appear under "nominated but withdrawn".

  87. 87

    Pharmacy Compounding Advisory Committee, 24 July 2026: Semax votes (official livestream) ↗

    Regulatory source

    Official livestream captions reviewed: 8 yes, 5 no, 1 abstain for Semax free base and for Semax acetate. Captions, not certified minutes.

  88. 88

    Pharmacy Compounding Advisory Committee, 23–24 July 2026: questions for the committee and final agenda ↗

    Regulatory source

    Official documents reviewed; list the Semax free base and acetate votes.

  89. 89

    21 CFR 216.23: bulk drug substances that can be used to compound drugs under section 503A ↗

    Regulatory source

    Current text and version history checked; Semax is not listed, and the section has not changed since 2019.

  90. 90

    Federal Register search: Semax ↗

    Regulatory source

    Search checked; only the July 2026 meeting notice, no proposed or final rule.

  91. 91

    Bulk drug substances nominated for use in compounding under section 503A of the FD&C Act (categories list) ↗

    Regulatory source

    Official PDF checked; not updated after the July 2026 vote.

  92. 92

    Unauthorized injectable peptide drugs seized and sold by Canada Peptide may pose serious health risks ↗

    Regulatory source

    Official advisory checked; names Semax, Selank and Pinealon among seized unauthorized injectable peptides.

  93. 93

    Standard for the Uniform Scheduling of Medicines and Poisons (Poisons Standard), June 2026 ↗

    Regulatory source

    Official instrument searched; Semax is not named.

  94. 94

    Government Order No. 3867-r (18 Dec 2025): list of vital and essential medicines ↗

    Regulatory source

    Official text reviewed in Russian; Semax (by its chemical name) is listed as nasal drops under N06BX.

  95. 95

    Semax: Ukrainian registration instructions (UA/1565/01/01) ↗

    Regulatory source

    Registration text reviewed; the registration has expired and no current Ukrainian registration was found.

  96. 96

    World Anti-Doping Code: 2026 Prohibited List ↗

    Regulatory source

    Official list checked; Semax is not named. Sport rules, not clinical evidence.

  97. 97

    World Anti-Doping Code: 2027 Prohibited List ↗

    Regulatory source

    Official list checked; Semax is not named. Sport rules, not clinical evidence.

  98. 98

    Semax 2 Week Experience ↗

    Public community

    Archived post and replies reviewed. Personal accounts, not clinical outcomes.

  99. 99

    Semax 0.1% – Spacey, antisocial? but better focus? ↗

    Public community

    Archived post and replies reviewed. Personal accounts, not clinical outcomes.

  100. 100

    Chronic Semax & Decreased Verbal fluidity / Word Recall ↗

    Public community

    Archived post and replies reviewed. Personal accounts, not clinical outcomes.

  101. 101

    Review of Semax nasal drops (in Russian) ↗

    Public community

    Public review reviewed in the original language. A personal account, not a clinical outcome.

  102. 102

    Semax (Injection vs. Nasal Spray) ↗

    Public community

    Archived post and replies reviewed. Personal accounts, not clinical outcomes.

  103. 103

    no effects on semax/selank ↗

    Public community

    Archived post and replies reviewed. Personal accounts, not clinical outcomes.

  104. 104

    Do you prefer semax nasal spray or injections? ↗

    Public community

    Archived post and replies reviewed. Personal accounts, not clinical outcomes.

  105. 105

    Semax is like Adderall but feels much cleaner ↗

    Public community

    Archived post and replies reviewed. Personal accounts, not clinical outcomes.

  106. 106

    Does semax Even works ? ↗

    Public community

    Archived post and replies reviewed. Personal accounts, not clinical outcomes.

  107. 107

    Passing out from Semax??? ↗

    Public community

    Archived post and replies reviewed. Personal accounts, not clinical outcomes.

  108. 108

    Review of Semax nasal drops (in Russian) ↗

    Public community

    Public review reviewed in the original language. A personal account, not a clinical outcome.

  109. 109

    Selank: instructions for use (current RLS entry) ↗

    Official product label

    Selected original full-text sections reviewed.

  110. 110

    Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia ↗

    Human study (Selank)

    Original abstract reviewed: 62 patients, Selank 30 versus medazepam 32. Selank data; context only.

  111. 111

    Selank 0.15% nasal drops: drug reference entry ↗

    Official product label

    Entry reviewed in Russian: non-prescription 0.15% nasal drops for anxiety states, neurasthenia and stress. A different drug from Semax; context only.

  112. 112

    Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agents ↗

    Animal study

    Original abstract reviewed. The journal published an expression of concern about this paper in 2021.

  113. 113
  114. 114

    Pinealon increases cell viability by suppression of free radical levels and activating proliferative processes ↗

    Cell study (Pinealon)

    Original article reviewed; identifies Pinealon as Glu-Asp-Arg. Context only.

  115. 115

    The peptide correction of neurotic disorders among professional truck-drivers ↗

    Human study (Pinealon)

    Original abstract reviewed; Pinealon was combined with another peptide. Context only.

  116. 116

    Effects of semax and its Pro-Gly-Pro fragment on calcium homeostasis of neurons and their survival under conditions of glutamate toxicity ↗

    Cell study

    Original abstract reviewed.

  117. 117

    The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysis ↗

    Animal study

    Selected original full-text sections reviewed.

  118. 118

    Semax and Pro-Gly-Pro activate the transcription of neurotrophins and their receptor genes after cerebral ischemia ↗

    Animal study

    Original abstract reviewed.

  119. 119

    C-terminal Pro-Gly-Pro tripeptide in contrast to full-length neuropeptide semax exhibits no neuroprotective effect in experimental cerebral ischemia ↗

    Animal study

    Original abstract reviewed.

  120. 120

    Audiogenic epilepsy in young mice of different strains after neonatal semax treatment ↗

    Animal study

    Original abstract reviewed.

  121. 121

    The influence of oligopeptides on spontaneous carcinogenesis in mice ↗

    Animal study

    Selected original full-text sections reviewed.

  122. 122

    The neuroprotective effects of Semax in conditions of MPTP-induced lesions of the brain dopaminergic system ↗

    Animal study

    Original abstract reviewed.

Updates and corrections

Corrected September 24, 2026. The ADHD section now describes the one small comparison summarized in a Russian review instead of saying there was none; the contraindication wording follows the current label (acute psychiatric illness rather than psychosis); the healthy-volunteer, cortisol, seizure-report, titration and tumour-study details were made more precise; and three personal accounts are described more accurately.

Updated September 23, 2026. This is the first version of the guide in its new format. It replaces an earlier, shorter reference page with a full review of the Russian labels, human studies, regulatory status, dosing sources and community experience, and adds sections on storage, what happens when people stop, what to monitor and how Semax compares with related peptides. Verified points from the earlier page were carried over. Corrections: the earlier page's daily range for the 0.1% drops (500–5,000 mcg for 3–5 days) came from a 2008 label; the current label gives 800–8,000 mcg a day for 10–14 days for circulation-related memory problems. The 1% stroke drops are a registered product in their own right, and the earlier description of Semax as working "without triggering stress hormones" was removed because the one human study that measured cortisol found it higher. The date describes this revision, not a fresh check of every source.

Found an error or a relevant study we missed? Report a correction with the guide title, the specific passage and a supporting source if available. Please leave out personal health records. See our editorial policy for how we handle attribution, evidence limits and corrections.